Piscataway, NJ, September 23, 2015– Camber Pharmaceuticals is pleased to announce that it has launched Esomeprazole Magnesium Delayed-Release Capsules, 20mg and 40mg which is the generic version of Nexium® capsules. Nexium® is used to treat heartburn, gastroesophageal reflux disease (GERD), stomach ulcers, and a damaged esophagus.
Esomeprazole is available from Camber in 30, 90 and 1000 count bottles for both strengths.
“Esomeprazole represents another very significant product in the growth of our organization” said Kon Ostaficiuk, President of Camber. “Our parent company, Hetero Labs, has received final approval for the Esomeprazole ANDA from the USFDA and has invested in the technology used to manufacture this challenging product and the results are reflected the scale of our capacities. We are happy that patients have a more affordable treatment option”.
Ostaficiuk added, “Our product pipeline continues to be impressive and it shows Camber’s commitment to provide affordable medications in a wide variety of formulations and therapies in the US.”
If you would like more information about this topic, please contact Megan Becker at 732.529.0436 or email at email@example.com.